JDK, a leading company focused on the development of pharmaceutical intermediates and basic chemicals, announced that their Ferulic Acid product has received CE certification. This certification verif

JDK, a leading pharmaceutical company specializing in the development of pharmaceutical intermediates and basic chemicals, has recently announced the development and production of a new veterinary dru

JDK, a company with a professional team equipped with specialized and interdisciplinary technical talents, has been making headlines with its latest product, Tiamulin Hydrogen Fumarate 80%. This pharm

JDK Pharmaceuticals Introduces Amoxicillin Trihydrate Compacted to Their Product Line JDK Pharmaceuticals is proud to announce the addition of Amoxicillin Trihydrate Compacted to their extensive rang

JDK Introduces Calcium Magnesium Phytase, a Breakthrough in Pharmaceutical Intermediates JDK, a leading company in the development of pharmaceutical intermediates and basic chemicals, has recently in

JDK, a company specializing in the development of pharmaceutical intermediates and basic chemicals, has announced a significant breakthrough in the development of a new product with the Cas No. 626-55

ODM Glutamic Acid has been making headlines in the pharmaceutical industry with its innovative approach to pharmaceutical intermediates and basic chemicals. ODM Glutamic Acid, developed by a professio

JDK Pharmaceuticals' Breakthrough in the Development of Ethyl 2-Cyanoacetoacetate JDK Pharmaceuticals, a leading company in the development of pharmaceutical intermediates and basic chemicals, has re

JDK Introduces New Breakthrough in Pharmaceutical Intermediates JDK is proud to announce a new breakthrough in pharmaceutical intermediates with the development of Sulfurol FEMA. This innovative prod

JDK, a leading pharmaceutical company with a focus on the development of pharmaceutical intermediates and basic chemicals, has recently launched a high-quality Astragalus Polysaccharide Oral Liquid, a